Autologous ovarian grafting may preserve ovarian function in young cervical cancer patients undergoing pelvic radiotherapy
Small trial tests ovarian tissue graft to protect hormone function during cervical cancer radiation
An exploratory phase II randomized trial of 22 women aged ≤35 years with locally advanced cervical cancer found that at six months, 85% of p…
A new trial shows grafting ovarian tissue before cervical cancer radiation kept 85% of young patients' hormone levels normal and prevented e…
Machine learning models show predictive potential for uterine fibroid treatment outcomes in meta-analysis
Can AI predict if fibroid treatments will work for you?
A systematic review and meta-analysis of 14 studies in women with uterine fibroids found machine learning models, particularly combined radi…
A new analysis suggests machine learning could one day predict if fibroid treatments will work for you, though the technology isn't ready fo…
Pembrolizumab ranks highest for survival in cervical cancer network meta-analysis
Review finds pembrolizumab may improve survival in advanced cervical cancer
A Bayesian network meta-analysis of phase 3 RCTs compared immune checkpoint inhibitors in locally advanced and metastatic cervical cancer.
Adding pembrolizumab to standard treatment for advanced cervical cancer is linked to better survival and longer time before the disease prog…
Lead exposure in LAC children linked to cognitive deficits, behavioral changes, and adverse birth outcomes
How does lead exposure affect children and pregnant women in Latin America?
A systematic review of 22 observational studies in Latin America and the Caribbean found some children had blood lead levels exceeding 3.5 μ…
Lead exposure in Latin America links to cognitive deficits and learning difficulties in children, plus premature births and low birth weight…
Expert consensus identifies policy gaps limiting ART access in Asia Pacific region
Why is it so hard to get fertility help in Asia Pacific countries?
An expert consensus and literature review of fertility policy in the Asia Pacific region found many countries have been slow to recognize in…
Infertility isn't recognized as a disease in many Asia Pacific countries, leading to little funding, no insurance for IVF, and public misund…
MPA vs GnRH antagonist for LH surge prevention in ART shows higher oocyte yield in fertility preservation cycles
Could a common pill help women freeze more eggs for the future?
A retrospective observational cohort study of 2,964 ART cycles at a Chilean fertility clinic compared oral medroxyprogesterone acetate (MPA)…
A common oral pill helped women freeze more mature eggs for the future than standard daily injections in a review of nearly 3,000 fertility …
Letrozole reduces Ki67 in postmenopausal ER+/HER2- breast cancer after 7-30 days pre-surgery
Can a short course of letrozole before surgery help shrink hormone-sensitive breast cancer?
A phase 2 trial of 61 postmenopausal women with ER+/HER2- operable breast cancer evaluated a 7- to 30-day preoperative course of letrozole 2…
Doctors can now get a real-time snapshot of how hormone-sensitive breast cancer responds to letrozole before surgery in postmenopausal women…
Sentinel lymph node technique assessed in multifocal breast cancer (n=216)
Can doctors find the first lymph node cancer might reach in women with multiple breast tumors?
A phase 2 trial assessed the sentinel lymph node technique in 216 patients with multifocal breast cancer.
Doctors successfully mapped the first lymph node cancer reaches in women with multiple breast tumors using a safe dye and tracer injection t…
Phase 3 trial compares pembrolizumab with or without lenvatinib in PD-L1+ recurrent/metastatic HNSCC
Phase 3 trial tests pembrolizumab with or without lenvatinib for advanced head and neck cancer
A phase 3 randomized controlled trial enrolled 511 patients with PD-L1 selected recurrent or metastatic head and neck squamous cell carcinom…
A completed Phase 3 trial tested pembrolizumab with or without lenvatinib for advanced head and neck cancer, but detailed results are not ye…
Phase II trial tests induction chemo with carboplatin, paclitaxel, lapatinib before transoral surgery in SCCHN
Can a gentler, three-part treatment plan reduce side effects for head and neck cancer?
A single-arm phase II trial enrolled 40 previously untreated patients with SCCHN amenable to transoral surgery.
A three-part treatment plan for head and neck cancer aims to reduce harsh side effects by tailoring care based on surgery results.
Phase II trial of cyclophosphamide, paclitaxel, trastuzumab in stage I-II HER2+ breast cancer completes with 20 patients
Can a shorter, more intense chemo regimen help prevent early-stage HER2-positive breast cancer from returning?
A phase II trial evaluated a dose-dense regimen of cyclophosphamide, paclitaxel, and trastuzumab after surgery in 20 patients with stage I-I…
For women with early-stage HER2-positive breast cancer, a key question is whether a shorter, more intense chemotherapy schedule after surger…
Triapine Added to Cisplatin and Radiation for Cervical/Vaginal Cancer: Phase III Results
Could a new drug boost survival for women with advanced cervical and vaginal cancers?
Phase III trial evaluates triapine with cisplatin and radiation vs. standard treatment for advanced cervical and vaginal cancers.
A new drug called triapine may help women with advanced cervical and vaginal cancers live longer when added to standard radiation and chemot…